O75164 (KDM4A_HUMAN) Homo sapiens (Human)
Lysine-specific demethylase 4A UniProtKBInterProInteractive Modelling
1064 aa; Sequence (Fasta) ; (Isoform 2; )
Sequence Features
188 | Iron; catalytic | ||
190 | Iron; catalytic | ||
234 | Zinc | ||
240 | Zinc; via tele nitrogen | ||
276 | Iron; catalytic | ||
306 | Zinc | ||
308 | Zinc | ||
482 | A -> E (in dbSNP:rs586339) VAR_023775 dbSNP | ||
877 | V -> G (in dbSNP:rs12759032) VAR_031217 dbSNP | ||
709-767 | PHD-type 1 | ||
772-805 | C2HC pre-PHD-type | ||
828-885 | PHD-type 2 | ||
15-49 | JmjN domain IPR003349PF02375 | ||
175-291 | JmjC domain IPR003347PF02373 | ||
902-936 | Lysine-specific demethylase 4, Tudor domain IPR040477PF18104 | ||
960-994 | Lysine-specific demethylase 4, Tudor domain IPR040477PF18104 |
Sequence Alignments
Experimental structures
Description | Oligo-state | Ligands | Structure | Range |
---|---|---|---|---|
JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H4(1-15)R3me2s PEPTIDE |
Heteromer P62805; | 1×NI; 1×ZN; 1×CL; 1×OGA; 1×GOL; | 5fwe | |
Assess | ||||
Crystal structure of human KDM4A complexed with co-substrate analog NOG and histone H3 peptide with… |
Heteromer P68431; | 2×ZN; 1×OGA; | 6hgt | |
Assess | ||||
Crystal structure of JMJD2A complexed with histone H3 peptide dimethylated at Lys9 |
Heteromer P68431; | 1×NI; 1×ZN; 1×CL; 1×OGA; | 2ox0 | |
Assess | ||||
JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41) |
Heteromer Q16695; | 1×NI; 1×ZN; 1×GOL; 1×2HG; | 2ybp | |
Assess | ||||
Crystal structure of JMJD2A complexed with histone H3 peptide monomethylated at Lys9 |
Heteromer P68431; | 1×NI; 1×ZN; 1×OGA; | 2ot7 | |
Assess | ||||
JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27me3 PEPTIDE (16-35) |
Heteromer Q16695; | 1×NI; 1×ZN; 1×CL; 1×OGA; 1×GOL; | 4v2w | |
Assess | ||||
Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys9 |
Heteromer P68431; | 1×NI; 1×ZN; 1×OGA; | 2oq6 | |
Assess | ||||
JMJD2A COMPLEXED WITH S-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41) |
Heteromer Q16695; | 1×NI; 1×ZN; 1×GOL; 1×S2G; | 2ybs | |
Assess | ||||
The complex structure of JMJD2A and trimethylated H3K36 peptide |
Heteromer | 1×ZN; 1×FE2; 1×OGA; 2×OXY; | 2p5b | |
Assess | ||||
JMJD2A/ KDM4A COMPLEXED WITH NI(II), NOG AND Histone H1.4(18-32)K26me3 peptide (15-mer) |
Heteromer P10412; | 1×NI; 1×ZN; 1×CL; 1×OGA; 3×GOL; | 6h8p | |
Assess | ||||
Histone Lysine demethylase JMJD2A in complex with T11C peptide substrate crosslinked to N-oxalyl-D-… |
Heteromer P68431; | 1×NI; 1×ZN; 1×08P; | 3u4s | |
Assess | ||||
JMJD2A tandem tudor domains in complex with a trimethylated histone H4-K20 peptide |
Heteromer P62805; | 2qqs | ||
Assess | ||||
Crystal structure of double tudor domain of human lysine demethylase KDM4A complexed with histone H… |
Heteromer P68431; | 5d6y | ||
Assess | ||||
JMJD2A/ KDM4A COMPLEXED WITH NI(II) AND Macrocyclic PEPTIDE Inhibitor CP2 (13-mer) | homo-4-mer | 4×NI; 4×ZN; 3×CL; 5×GOL; 3×PPI; | 5ly1 | |
Assess | ||||
JMJD2A/ KDM4A COMPLEXED WITH NI(II), NOG AND Macrocyclic PEPTIDE Inhibitor CP2_R6Kme3 (13-mer) | homo-4-mer | 4×NI; 4×ZN; 4×OGA; 5×GOL; 5×CL; | 5ly2 | |
Assess | ||||
Crystal structure of JMJD2A complexed with bipyridyl inhibitor | monomer | 1×NI; 1×ZN; 1×KC6; 4×CL; 1×NA; | 3pdq | |
Assess | ||||
Crystal Structure of KDM4A with compound YP-02-145 | monomer | 1×ZN; 3×NI; 2×EDO; 2×CIT; 1×GOL; | 6g5x | |
Assess | ||||
Crystal structure of human JMJD2A in complex with compound 30 | monomer | 2×MN; 1×KCH; 1×ZN; 2×CL; | 5a7q | |
Assess | ||||
Crystal structure of human JMJD2A in complex with pyruvate | monomer | 1×NI; 2×PYR; 1×DMS; 9×EDO; 1×ZN; | 5fyi | |
Assess | ||||
Crystal structure of human JMJD2A in complex with compound 42 | monomer | 1×SO4; 1×7WH; 11×EDO; 1×ZN; 1×MN; 1×DMS; | 5a7o | |
Assess | ||||
Crystal Structure of JMJD2A Complexed with Inhibitor | monomer | 1×NI; 1×ZN; 1×HQ2; 1×GOL; | 3rvh | |
Assess | ||||
Crystal structure of human JMJD2A in complex with compound 40 | monomer | 1×SO4; 1×MN; 1×9CJ; 1×ZN; 5×EDO; | 5a80 | |
Assess | ||||
Crystal structure of human JMJD2A in complex with fumarate | monomer | 1×ZN; 1×FUM; 1×SO4; 1×MN; 1×EDO; | 5fyh | |
Assess | ||||
Crystal structure of human JMJD2A in complex with compound 43 | monomer | 1×MN; 1×ZN; 5×EDO; 1×SO4; 1×VAO; | 5a7n | |
Assess | ||||
Crystal Structure of KDM4A with Compound 14 | monomer | 1×NI; 1×ZN; 1×QC1; | 6cg1 | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 58 | monomer | 2×ZN; 1×N5J; 12×EDO; 2×DMS; | 5f37 | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 54j | monomer | 2×ZN; 1×5UJ; 1×DMS; | 5f3i | |
Assess | ||||
Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid | monomer | 1×NI; 1×ZN; 1×PD2; | 2vd7 | |
Assess | ||||
Crystal structure of human JMJD2A in complex with compound 36 | monomer | 1×SO4; 1×MN; 1×ZN; 4×EDO; 1×6Z1; 1×DMS; | 5a7p | |
Assess | ||||
Crystal Structure of JMJD2A Complexed with Inhibitor | monomer | 1×NI; 1×ZN; 1×CL; 1×0WS; | 4gd4 | |
Assess | ||||
Crystal structure of human JMJD2A in complex with D-threo-isocitrate | monomer | 1×NI; 1×ZN; 1×N81; 1×DMS; 3×EDO; | 5fy8 | |
Assess | ||||
Crystal Structure of Human KDM4 with Small Molecule Inhibitor QC5714 | monomer | 1×NI; 1×ZN; 1×9FJ; | 5vmp | |
Assess | ||||
Crystal Structure of KDM4A with compound YP-03-038 | monomer | 1×ZN; 2×NI; 2×EDO; 2×CIT; | 6g5w | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 17f | monomer | 2×ZN; 1×FQB; 1×DMS; 1×GOL; | 6h4r | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 34g | monomer | 2×ZN; 1×FQN; 1×CL; 2×DMS; | 6h4v | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 54a | monomer | 2×ZN; 1×5UO; 1×DMS; | 5f3e | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 16a | monomer | 2×ZN; 1×FQ5; 3×DMS; 1×CL; | 6h4p | |
Assess | ||||
Crystal structure of human JMJD2A in complex with compound 14a | monomer | 1×EDO; 1×SO4; 1×NI; 1×ZN; 1×LEL; | 4ura | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 17b | monomer | 2×ZN; 1×FNQ; 1×DMS; 1×GOL; 1×CL; | 6h4x | |
Assess | ||||
Crystal structure of the catalytic core domain of jmjd2a | monomer | 1×ZN; 1×FE2; | 2gp3 | |
Assess | ||||
JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE | monomer | 1×NI; 1×ZN; 1×CL; 1×2HG; | 2ybk | |
Assess | ||||
Crystal Structure of human JMJD2A complexed with KDOOA011340 | monomer | 1×NI; 1×ZN; 1×SO4; 1×5V1; | 5f5i | |
Assess | ||||
JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27me3 PEPTIDE (25-29) ARK(me3)SA | monomer | 1×OGA; 1×NI; 1×ZN; | 4v2v | |
Assess | ||||
JMJD2A in complex with Ni(II) and alpha-Ketoglutarate | monomer | 1×NI; 1×AKG; 1×ZN; | 5tvr | |
Assess | ||||
JMJD2A Complexed with Daminozide | monomer | 1×NI; 1×ZN; 1×CL; 2×DZA; | 4ai9 | |
Assess | ||||
Crystal Structure of KDM4A with Compound 8 | monomer | 1×NI; 1×ZN; 1×QC2; | 6cg2 | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 19a | monomer | 2×ZN; 1×FOW; 1×CL; | 6h4t | |
Assess | ||||
JMJD2A COMPLEXED WITH 8-HYDROXYQUINOLINE-4-CARBOXYLIC ACID | monomer | 1×NI; 1×ZN; 1×CL; 1×8HQ; 1×GOL; | 4bis | |
Assess | ||||
JMJD2A in complex with Ni(II) | monomer | 1×NI; 1×ZN; | 5tvs | |
Assess | ||||
The complex structure of JMJD2A and monomethylated H3K36 peptide | monomer | 1×ZN; 1×FE2; 1×OGA; | 2pxj | |
Assess | ||||
The crystal structure of JMJD2A complexed with Ni and N-oxalylglycine | monomer | 1×NI; 1×ZN; 1×OGA; | 2oq7 | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 18a | monomer | 2×ZN; 1×FQH; 1×GOL; 1×CL; | 6h4o | |
Assess | ||||
Crystal structure of catalytic core domain of jmjd2A complexed with alpha-Ketoglutarate | monomer | 1×ZN; 1×FE2; 1×AKG; | 2gp5 | |
Assess | ||||
Crystal structure of JMJ2D2A in ternary complex with histone H3-K36me2 and succinate | monomer | 1×NI; 1×ZN; 1×SIN; | 2q8d | |
Assess | ||||
Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys36 | monomer | 1×NI; 1×ZN; 1×OGA; | 2os2 | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 34a | monomer | 2×ZN; 1×FO2; 2×GOL; 1×DMS; | 6h4q | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 16m | monomer | 2×ZN; 1×FQE; 3×DMS; | 6h4s | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 53a | monomer | 2×ZN; 1×5UL; 2×DMS; | 5f3g | |
Assess | ||||
Crystal structure of JMJD2A complexed with 5-carboxy-8-hydroxyquinoline | monomer | 1×NI; 1×ZN; 1×8XQ; | 3njy | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 19d | monomer | 2×ZN; 1×FQQ; 1×DMS; 1×CL; | 6h4w | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 15 | monomer | 2×ZN; 1×5TZ; 7×EDO; 2×DMS; | 5f2s | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 34b | monomer | 2×ZN; 1×FO2; 1×DMS; 1×GOL; 1×CL; | 6h4u | |
Assess | ||||
Crystal structure of human JMJD2A in complex with succinate | monomer | 1×NI; 1×ZN; 1×FUM; 5×EDO; 1×SO4; | 5fyc | |
Assess | ||||
Crystal structure of human JMJD2A in complex with compound 35 | monomer | 1×SO4; 1×35M; 1×MN; 1×ZN; 2×EDO; 1×DMS; | 5a7w | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 17e | monomer | 2×ZN; 1×FO8; 1×CL; | 6h4y | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 16 | monomer | 2×ZN; 1×5UP; 3×EDO; 1×DMS; | 5f2w | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 37 | monomer | 2×ZN; 1×5UB; 4×DMS; | 5f39 | |
Assess | ||||
Crystal structure of JMJD2A in ternary complex with an histone H3K9me3 peptide and 2-oxoglutarate | monomer | 1×NI; 1×ZN; 1×AKG; | 2q8c | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 52d | monomer | 2×ZN; 1×5U8; 4×DMS; 1×GOL; | 5f3c | |
Assess | ||||
Crystal Structure of KDM4 with the Small Molecule Inhibitor QC6352 | monomer | 1×NI; 1×ZN; 1×9DJ; | 5vgi | |
Assess | ||||
Crystal structure of human JMJD2A in complex with compound 44 | monomer | 1×MN; 1×ZN; 7×EDO; 1×S2X; 1×DMS; | 5a7s | |
Assess | ||||
Crystal structure of human JMJD2A in complex with compound KDOAM20A | monomer | 1×MN; 1×MMK; 1×ZN; 3×NI; | 5fpv | |
Assess | ||||
inhibitors of JumonjiC domain-containing histone demethylases | monomer | 1×5YQ; 1×FE2; 2×SO4; 1×ZN; 3×CL; | 5anq | |
Assess | ||||
Specificity and Mechanism of JMJD2A, a Trimethyllysine-Specific Histone Demethylase | monomer | 1×NI; 1×ZN; 1×OGA; | 2q8e | |
Assess | ||||
Crystal structure of human KDM4A in complex with compound 40 | monomer | 2×ZN; 1×5V7; 1×DMS; 1×EDO; 1×GOL; | 5f32 | |
Assess | ||||
JMJD2A hybrid tudor domains | monomer | 3×SO4; | 2qqr | |
Assess | ||||
Crystal structure of double tudor domain of human lysine demethylase KDM4A | monomer | 1×SRT; | 5d6w | |
Assess | ||||
Crystal structure of double tudor domain of human lysine demethylase KDM4A | monomer | 2×SO4; | 5d6x | |
Assess | ||||
Double tudor domain structure | monomer | 1×SO4; | 2gf7 | |
Assess | ||||
double tudor domain complex structure | monomer | 2gfa | ||
Assess | ||||
The Crystal Structure of human JMJD2A Tudor domain from Biortus | monomer | 1×SO4; | 7d4a | |
Assess | ||||
Crystal structure of KDM4A tandem TUDOR domain in complex with a tri-methyl lysine competitive inhi… | monomer | 1×92Y; | 5var | |
Assess |
Homology models
Oligo-state | QMEAN | Template | Range | Seq id (%) | Ligands |
---|---|---|---|---|---|
monomer | 0.02 | 2xdp.1.A | 65.83 | ||
Assess | |||||
monomer | -3.27 | 6u04.1.A | 39.35 | 4×ZN; | |
Assess | |||||
monomer | -2.74 | 5zcj.1.C | 24.11 | ||
Assess |
Homology models built on isoform sequence
Isoform | Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | monomer | 1×SRT; | 0.98 | 5d6w.1.A | 100.00 | |
Assess | ||||||
Isoform 2 | monomer | 0.11 | 2xdp.1.A | 67.52 | ||
Assess | ||||||
Isoform 2 | monomer | 3×ZN; | -4.01 | 5erc.1.A | 39.87 | |
Assess | ||||||
Isoform 2 | monomer | -2.72 | 5zcj.1.C | 24.11 | ||
Assess |